• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

顺式二氯二氨铂II和阿霉素对复发性卵巢癌的化疗

Chemotherapy of recurrent ovarian carcinoma with cis-dichlorodiammine platinum II and adriamycin.

作者信息

Wallach R C, Cohen C, Bruckner H, Kabakow B, Deppe G, Ratner L

出版信息

Obstet Gynecol. 1980 Mar;55(3):371-2. doi: 10.1097/00006250-198003000-00020.

DOI:10.1097/00006250-198003000-00020
PMID:7189048
Abstract

Forty-six patients with recurrent disseminated ovarian carcinoma were treated with a combination of cis-dichlorodiammine platinum II (DDP) 50 mg/m2 and adriamycin 50 mg/m2 given intravenously every 3 weeks. All patients had failed prior chemotherapy. The combination of adriamycin and DDP produced objective responses in 14 of 46 patients. Severe side effects were frequent, but no patient died as a result of treatment. Disease in 4 of 7 complete responders is currently in remission up to 4 years.

摘要

46例复发性播散性卵巢癌患者接受了顺式二氯二氨铂II(DDP)50mg/m²和阿霉素50mg/m²联合治疗,每3周静脉给药一次。所有患者先前的化疗均告失败。阿霉素与DDP联合用药使46例患者中的14例产生了客观反应。严重副作用很常见,但没有患者因治疗而死亡。7例完全缓解患者中有4例的疾病目前已缓解长达4年。

相似文献

1
Chemotherapy of recurrent ovarian carcinoma with cis-dichlorodiammine platinum II and adriamycin.顺式二氯二氨铂II和阿霉素对复发性卵巢癌的化疗
Obstet Gynecol. 1980 Mar;55(3):371-2. doi: 10.1097/00006250-198003000-00020.
2
[Combination of adriamycin and cis-diammine-dichloro-platinum (II) in the treatment of advanced, therapy-resistant, ovarian carcinoma (author's transl)].阿霉素与顺二氨二氯铂(II)联合治疗晚期、耐药性卵巢癌(作者译)
Dtsch Med Wochenschr. 1978 Jun 2;103(22):927-31. doi: 10.1055/s-0028-1104800.
3
Adriamycin and cis-platinum in advanced ovarian cancer.
Eur J Cancer Clin Oncol. 1985 Jun;21(6):665-9. doi: 10.1016/0277-5379(85)90262-7.
4
[Treatment of advanced ovarian cancer with cis-dichlorodiammine platinum (CDDP) as single agent or cddp in combination with adriamycin (ADM)].[以顺二氯二氨铂(CDDP)作为单一药物或CDDP与阿霉素(ADM)联合治疗晚期卵巢癌]
Gan To Kagaku Ryoho. 1983 Apr;10(4 Pt 1):938-43.
5
Treatment of ovarian cancer with a combination of cis-platinum, adriamycin, cyclophosphamide and hexamethylmelamine.
Oncology. 1982;39(4):205-8. doi: 10.1159/000225638.
6
High-dose cis-platinum in combination with adriamycin in the treatment of ovarian carcinoma.大剂量顺铂联合阿霉素治疗卵巢癌。
Eur J Gynaecol Oncol. 1984;5(3):203-6.
7
cis-Dichlorodiammineplatinum(II) and adriamycin treatment of advanced ovarian cancer.顺二氯二氨合铂(II)与阿霉素联合治疗晚期卵巢癌
Cancer Treat Rep. 1978 Dec;62(12):2027-30.
8
[Ovarian adenocarcinoma stage III and IV treated by a combination of adriamycin, cyclophosphamide, 5-fluorouracil and cis-DDP. Therapeutic role of cis-DDP in this combination].
Bull Cancer. 1982;69(5):434-42.
9
Cis-Dichlorodiammine platinum and adriamycin therapy for advanced gynecological and genitourinary neoplasms.顺二氯二氨铂和阿霉素治疗晚期妇科及泌尿生殖系统肿瘤
Cancer. 1980 Oct 15;46(8):1715-21. doi: 10.1002/1097-0142(19801015)46:8<1715::aid-cncr2820460802>3.0.co;2-h.
10
Combination chemotherapy of advanced ovarian cancer with hexamethylmelamine, cis-Platinum, and doxorubicin after failure of prior therapy.
Obstet Gynecol. 1980 Nov;56(5):635-40.

引用本文的文献

1
In vitro evaluation of cisplatin interaction with doxorubicin or 4-hydroperoxycyclophosphamide against human gynecologic cancer cell lines.顺铂与阿霉素或4-氢过氧环磷酰胺对人妇科癌细胞系相互作用的体外评估。
Cancer Chemother Pharmacol. 1989;25(2):89-94. doi: 10.1007/BF00692345.